Anti-citrullinated protein antibody (ACPA) positivity in rheumatoid arthritis patients is associated with a better response to treatment with abatacept but not TNF inhibitors. A study, using the Optimizing Patient outcomes in Australian RheumatoLogy (OPAL) dataset, assessed changes in disease activity over 12 months in more than 2,000 patients who commenced treatment between 2006 and 2017. ...
ACPA a biomarker of response to some biologics but not others
By Mardi Chapman
1 Oct 2020